Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT06093932
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT06093932
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06093932. Randomized; double masking; primary purpose treatment. Start 2024-04-07 (actual); primary completion 2024-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
- Acronym
- ESCIHP
- Condition
- Hypertension,Essential
- Intervention (Drug)
- Songling Xuemaikang Capsules
- Intervention (Behavioral)
- Lifestyle intervention
- Intervention (Drug)
- Placebo
- Lead sponsor
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Collaborator
- Suzhou Hosptial of Traditional Chinese Medicine
- Collaborator
- Shandong University of Traditional Chinese Medicine
Record details
- Record id
cardio:ct-nct06093932- Content hash
4364f685ada2a5cac89c495ecdcad0265ea30a2cf0c4b6ca9fdee9179bfda624